At SXSW, Cuban and eMed CEO Draw Contrast Between Them and Other “Marketing” Companies
Mark Cuban, co-founder of Cost Plus Drugs, and Linda Yaccarino, CEO of the employer GLP-1 platform eMed Population Health, were at SXSW drawing a contrast between their approach to GLP-1 drugs and that of other direct-to-consumer companies. They also announced a collaboration where Cost Plus Drugs will be one of eMed's distribution partners.
